AYDOS, U. Et Al. 2020. F-18-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of F-18-FDG PET positivity and prognostic value of PET derived metabolic parameters. NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.11 , 1199-1209.

AYDOS, U., TAHTACI, G., Ozgur Akdemir, Ü. Ö., & ÖZET, A., (2020). F-18-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of F-18-FDG PET positivity and prognostic value of PET derived metabolic parameters. NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.11, 1199-1209.

AYDOS, UĞURAY Et Al. "F-18-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of F-18-FDG PET positivity and prognostic value of PET derived metabolic parameters," NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.11, 1199-1209, 2020

AYDOS, UĞURAY Et Al. "F-18-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of F-18-FDG PET positivity and prognostic value of PET derived metabolic parameters." NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.11, pp.1199-1209, 2020

AYDOS, U. Et Al. (2020) . "F-18-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of F-18-FDG PET positivity and prognostic value of PET derived metabolic parameters." NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.11, pp.1199-1209.

@article{article, author={UĞURAY AYDOS Et Al. }, title={F-18-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of F-18-FDG PET positivity and prognostic value of PET derived metabolic parameters}, journal={NUCLEAR MEDICINE COMMUNICATIONS}, year=2020, pages={1199-1209} }